Neuraltus Pharmaceuticals Receives $17,000,000 Series A Financing Round

  • Feed Type
  • Date
    3/26/2009
  • Company Name
    Neuraltus Pharmaceuticals
  • Mailing Address
    Undisclosed Menlo Park, CA 94025
  • Company Description
    Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing innovative small molecule therapeutics for the treatment of neurodegenerative disorders.
  • Website
    http://www.neuraltus.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Latterell Venture Partners
  • Venture Investor
    VantagePoint Venture Partners
  • Venture Investor
    Adams Street Partners

By posting a comment, you agree to our terms and conditions.